Global Blood Plasma Products Market to Reach $45.7 Billion by 2027: Players Include ADMA Biologics, Baxter International, Bio Products Laboratory, China Biologic Products and CSL Behring - ResearchAndMarkets.com

23 Feb 2023
www.businesswire.com
DUBLIN--(BUSINESS WIRE)--The "Global Markets for Blood Plasma Products" report has been added to ResearchAndMarkets.com's offering.
This research report presents an in-depth analysis of the global blood plasma products market by product type, application, end user and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma. The market is expected to reach $45.7 Billion by 2027 from $33.2 Billion in 2022.
Companies Mentioned
CSL Behring
Lfb Sa
The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. It also features an in-depth analysis of the key companies operating in the global blood plasma products market, and it surveys patents that highlight past, current and projected global technology trends.
The blood plasma products market is primarily segmented into five major categories: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report.
Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma products market is segmented into the following: hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.
In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the Rest of the World (RoW). Key regions like the U.S., Canada, Europe (U.K., Italy, France, Germany), China, India, Australia and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas.
This report includes estimates of market size using 2021 as the base year and forecasting forward to 2027. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers' total revenues.
A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market's supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches and pipeline products are provided.
Report Includes
44 data tables and 30 additional tables
An overview of the global market for blood plasma products
Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
Characterization and quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
Detailed information related to mode of delivery for blood plasma
Analysis of key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitorsprotease inhibitors, coagulation factor concentrates and other plasma fractionation products
In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centres and rising disease awareness and education
Profiles of the major players in the industry, including ADMA Biologics Inc., China Biologic Products Inc., Kedrion SpA, Octapharma AG, and Takeda Pharmaceutical Co. Ltd.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
3.1 Introduction to Blood Plasma Products
3.2 Components of Blood Plasma
3.3 Functions of Blood Plasma
3.4 Blood Donation
3.4.1 Collection and Extraction of Blood Plasma
3.4.2 Fractionation Methods for Extracting Individual Components from Plasma
3.5 Government Regulations: Fda, International Regulatory Agencies and Medical Associations
3.6 Clinical Guidelines
3.7 Market Dynamics
3.7.1 Drivers
3.7.2 Restraints
3.7.3 Opportunities
Chapter 4 Market Breakdown by Product Type
Chapter 5 Market Breakdown by Application
Chapter 6 Market Breakdown by End-user
Chapter 7 Market Breakdown by Region
Chapter 8 Mode of Delivery for Blood Plasma Products
8.2 Gels
8.3 Sprays
8.4 Biomedical Sealants
8.5 Other Modes of Delivery
8.5.1 Inhalation
8.5.2 Ophthalmic Drops
Chapter 9 Patent Review and Clinical Trial Landscape
9.1 Patent Review
9.2 Clinical Trials Landscape
Chapter 10 Impact of the Covid-19 Pandemic on the Market for Blood Plasma Products
10.1 Impact on the Blood Plasma Product Manufacturers
Chapter 11 Competitive Landscape
11.1 Overview
11.2 Major Players and Market Shares
11.3 Porter's Five Forces Analysis of the Market for Blood Plasma Products
11.4 Major Developments
11.5 Product Launches
11.6 Mergers and Acquisitions
11.7 Business Expansions
11.8 Agreements and Collaborations
Chapter 12 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/dh1t9m-markets?w=4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.